DoP Turns Down Neon Labs’ Appeal for Revising Steroid Drug Methylprednisolone’s Price Ceiling
The Department of Pharmaceuticals (DoP) has dismissed a request by Neon Laboratories, based in Mumbai, to re-evaluate the ceiling price determination set by the National Pharmaceutical Pricing Authority (NPPA) for the steroid medication methylprednisolone 40 mg/ml injectable. Neon Laboratories reached […]